[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Page 28072]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-9625]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 25, 2006, and published in the Federal 
Register on November 1, 2006, (71 FR 64298), Cambrex Charles City, 
Inc., 1205 11th Street, Charles City, Iowa 50616, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of Sufentanil (9740), a basic class of controlled 
substance listed in schedule II.
    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambrex Charles City, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Cambrex Charles City, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with State and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: May 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-9625 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P